Key result
Pulmonary annular systolic motion velocity (s1') was significantly higher in children with atrial septal defects (15.0 cm/s) and lower in those with pulmonary arterial hypertension (8.5 cm/s) or tetralogy of Fallot (5.3 cm/s) compared to healthy controls (11.2 cm/s).
Why the study?
Does measuring pulmonary annular motion velocity using Tissue Doppler Imaging accurately assess right ventricular outflow tract (RVOT) performance in pediatric patients with heart disease?
Observational (n=93)
Single-blind
No
Does measuring pulmonary annular motion velocity using Tissue Doppler Imaging accurately assess right ventricular outflow tract (RVOT) performance in pediatric patients with heart disease?
BACKGROUND: We assessed whether measuring pulmonary annular motion velocity could serve as a novel method of evaluating right ventricular outflow tract (RVOT) performance in pediatric patients with heart disease. METHODS AND RESULTS: Tissue Doppler-derived pulmonary annular motion velocity was determined from the parasternal long-axis view of the RVOT. Pulmonary annular velocity was measured in children (age, 5-10 years) with an atrial septal defect (ASD), pulmonary arterial hypertension (PAH), surgically repaired tetralogy of Fallot (TOF) and healthy children (control). Pulmonary annular velocity waveforms comprised systolic bimodal (s1' and s2') and diastolic e' and a' waves in all groups. The peak velocity of s1' and s2' was significantly higher in the ASD group than in the controls (15.0±2.4 vs. 11.2±2.1 and 6.0±0.9 vs. 4.4±1.2 cm/s; P<0.01 and P<0.001, respectively). The s1' and s2' peak velocities were significantly lower in the PAH group (8.5±1.2 and 3.2±0.4 cm/s; P<0.05 for both), and in the group with TOF (5.3±2.2 and 3.4±1.4 cm/s; P<0.001 and P<0.05, respectively). The peak velocity of e' was significantly decreased in the PAH and TOF, compared with the control group (6.8±1.6 and 8.2±2.9 vs. 11.9±1.9 cm/s; P<0.001 for both). CONCLUSIONS: Pulmonary annular motion velocity determined using tissue Doppler imaging is a promising method of assessing RVOT function.
No takes yet. Share an insight, caveat, or question.
Hayabuchi et al. (2015) conducted an observational in Congenital Heart Disease (ASD, PAH, TOF) (n=93). Congenital heart disease (ASD, PAH, TOF) vs. Healthy children (control) was evaluated on Peak velocity of pulmonary annular systolic wave (s1') in ASD vs Controls (p=<0.01). Pulmonary annular systolic motion velocity (s1') was significantly higher in children with atrial septal defects (15.0 cm/s) and lower in those with pulmonary arterial hypertension (8.5 cm/s) or tetralogy of Fallot (5.3 cm/s) compared to healthy controls (11.2 cm/s).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: